Serum calcium and incident type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study
- PMID: 27510541
- PMCID: PMC5039808
- DOI: 10.3945/ajcn.115.130021
Serum calcium and incident type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study
Abstract
Background: Elevated serum calcium has been associated with a variety of metabolic abnormalities and may be associated with a greater risk of diabetes.
Objective: The purpose of this study was to test the hypothesis that serum calcium concentration is positively and independently associated with the incidence of diabetes and to evaluate the association of calcium-sensing receptor (CaSR) gene single nucleotide polymorphism (SNP) rs1801725 with incident diabetes.
Design: Atherosclerosis Risk in Communities study participants free of diabetes at baseline (n = 12,800; mean age: 53.9 y; 22.6% black) were studied for incident diabetes. Serum calcium was measured at baseline and corrected for serum albumin. Diabetes was defined by use of glucose concentrations, self-report, or medication use. Cox proportional hazards regression was used.
Results: During a mean 8.8 y of follow-up, 1516 cases of diabetes were reported. Participants in the highest compared with lowest calcium quintile were at greater risk of incident diabetes after adjustment for demographic and lifestyle factors [HR (95% CI): 1.34 (1.14, 1.57); P-trend across quintiles <0.0001] and with further adjustment for waist circumference and body mass index [1.26 (1.07, 1.48); P-trend = 0.004]. Additional adjustment for biomarkers on the metabolic pathway (e.g., 25-hydroxyvitamin D, parathyroid hormone, phosphorus) had little impact. The calcium-diabetes association was statistically significant in blacks [1.48 (1.11, 1.98); P-trend = 0.002] but not whites [1.17 (0.96, 1.43); P-trend = 0.17] after adjustment for adiposity. In whites, CaSR gene SNP rs1801725 was associated with serum calcium but not with risk of diabetes.
Conclusions: Consistent with 3 previous cohort studies, elevated serum calcium was found to be associated with a greater risk of type 2 diabetes. Further research is needed to understand the role, if any, that calcium plays in the pathogenesis of diabetes.
Keywords: calcium-sensing receptor polymorphism; cohort study; diabetes mellitus; race; serum calcium.
© 2016 American Society for Nutrition.
Figures
Comment in
-
Metabolism: Calcium-T2DM link strengthens.Nat Rev Endocrinol. 2016 Nov;12(11):626. doi: 10.1038/nrendo.2016.146. Epub 2016 Aug 26. Nat Rev Endocrinol. 2016. PMID: 27564713 No abstract available.
-
Serum calcium and its complex association with incident type 2 diabetes.Am J Clin Nutr. 2016 Oct;104(4):957-958. doi: 10.3945/ajcn.116.143321. Epub 2016 Sep 14. Am J Clin Nutr. 2016. PMID: 27629050 Free PMC article. No abstract available.
References
-
- Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta (GA): Department of Health and Human Services; 2014.
-
- Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol 2010;5(Suppl 1):S23–30. - PubMed
-
- Kim MK, Kim G, Jang E, Kwon H, Baek K, Oh K, Lee J, Yoon K-H, Lee W, Lee K, et al. Altered calcium homeostasis is correlated with the presence of metabolic syndrome and diabetes in middle-aged and elderly Korean subjects: the Chungju Metabolic Disease Cohort study (CMC study). Atherosclerosis 2010;212:674–81. - PubMed
-
- Yamaguchi T, Kanazawa I, Takaoka S, Sugimoto T. Serum calcium is positively correlated with fasting plasma glucose and insulin resistance, independent of parathyroid hormone, in male patients with type 2 diabetes mellitus. Metabolism 2011;60:1334–9. - PubMed
-
- Sun G, Vasdev S, Martin GR, Gadag V, Zhang H. Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and β-cell function in the Newfoundland population. Diabetes 2005;54:3336–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K24 DK106414/DK/NIDDK NIH HHS/United States
- R01 DK089174/DK/NIDDK NIH HHS/United States
- R01 HL103706/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- HHSN268201100009C/HL/NHLBI NIH HHS/United States
- HHSN268201100010C/HL/NHLBI NIH HHS/United States
- HHSN268201100011C/HL/NHLBI NIH HHS/United States
- HHSN268201100012C/HL/NHLBI NIH HHS/United States
- N01HC65226/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
